Dental Care Clinics in Hampton Bays, NY Accepting Medicare
3 Dental Care Clinics found. Showing 1 - 3
 East End Oral Surgery Dentist - Oral and Maxillofacial Surgery Medicare: Not Enrolled in Medicare Practice Location: 240 W Montauk Hwy, Hampton Bays, NY 11946 Phone: 631-728-1300 Fax: 631-728-5165 |
Healthy Smiles Dental P.c. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 34 E Montauk Hwy Ste 2, Hampton Bays, NY 11946 Phone: 631-594-3100 |
Hampton Bays Dental Assoc. P.c. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 182 W Montauk Hwy, Bldg. B Ste. E, Hampton Bays, NY 11946 Phone: 631-728-8400 Fax: 631-728-8482 |
News Archive
Vitamin B12 may help protect against Alzheimer's disease
A new study shows that vitamin B12 may protect against Alzheimer's disease, adding more evidence to the scientific debate about whether the vitamin is effective in reducing the risk of memory loss. The research will be published in the October 19, 2010, issue of Neurology®, the medical journal of the American Academy of Neurology.
Wearable devices can identify COVID-19 cases earlier than traditional diagnostic methods
Wearable devices can identify COVID-19 cases earlier than traditional diagnostic methods and can help track and improve management of the disease, Mount Sinai researchers report in one of the first studies on the topic. The findings were published in the Journal of Medical Internet Research on January 29.
Foundation NHS trusts and teaching hospitals outperform others
Some NHS trusts consistently outperform others on a range of measures of patient experience, finds research published online in BMJ Quality & Safety.
Vitamin D may lower glucose levels and reduce risk of developing type 2 diabetes
The benefits of vitamin D in promoting bone health are already well known. A new study out of Brazil suggests that vitamin D also may promote greater insulin sensitivity, thus lowering glucose levels and the risk of developing type 2 diabetes.
ISTO announces completion of enrollment in NuQu Phase I clinical study for discogenic back pain
ISTO Technologies, Inc., an orthobiologics company with a cell-based platform for cartilage regeneration, announced today the completion of patient enrollment in the Phase I clinical study for NuQu™, an injectable formulation of juvenile chondrocytes designed for the treatment of discogenic back pain. The study included 15 patients enrolled at two clinical sites. All patients enrolled in the trial suffered from persistent discogenic back pain and disability despite undergoing previous traditional conservative therapy.
› Verified 6 days ago